Trademark Attorney / Law Firm

Karen McCloat – Trademark Portfolio

Karen McCloat specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 8 of 13 total filings concentrated in this category. The practice also covers Class 33 (Wine & Spirits) along with 5 other Nice Classification classes. Currently, 0 trademarks are registered.

13 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Karen McCloat's trademark practice covers 5 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

33
Wine & Spirits (2 filings)

Alcoholic beverages (except beers)

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademark applications has Karen McCloat filed?

Karen McCloat has filed 13 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does Karen McCloat specialize in?

Karen McCloat has filed trademarks across 5 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 33 (Wine & Spirits), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Karen McCloat's trademark registration success rate?

Karen McCloat has a 0% trademark registration rate, with 0 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.